Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis and Pregnancy

Richard Quinn  |  Issue: April 2015  |  April 1, 2015

“I don’t think it’s anything that is earth shattering, or that patients need to do anything different. But I do think pregnant [RA] patients should let their obstetricians know that they have RA and that this is a possibility.”

Tell Your Patients

The new information is something high-risk obstetrician Jeff Ecker, MD, wants his patients to communicate. He says the research confirms “a notion that had been supported by some data previously,” and is a step in the right direction for patients, rheumatologists and obstetricians.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We recognize that whenever there is inflammation in the body, whether it stems from an infection or lupus or RA, that there is a cascade that starts that can sometimes provoke preterm labor and delivery,” says Dr. Ecker, director of the maternal fetal medicine fellowship at Massachusetts General Hospital in Boston, and chair of the American College of Obstetrics and Gynecologists’ Committee on Obstetric Practice. “I think this information is very important. The more we can do to start out with a healthy mom, the better.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Ms. Ecker

Ms. Ecker

Dr. Ecker says that although the study results do not seem overly concerning, he notes that some women with RA may find the increased risks alarming. He says, for that reason, rheumatologists should add this information to their “normal” conversations with women of reproductive age.

“For women with RA who want to become pregnant, a visit in advance of pregnancy to consider these risks, and to consider their course and medications they are taking, is ideal,” he says. “These risks do not seem enormous to me, but there might be some out there that say, ‘Oh my, I’m at this higher risk for preterm labor and delivery. Nope, I’m not going to get pregnant.’ It’s better for them to understand that in advance than for me to be seeing them at 15 weeks and the patient saying, ‘Oh, I wish I had known that.’”

What it all comes down to is a better-informed patient, he adds.

“For women [who] don’t want to become pregnant, because their RA is active or their meds are not great to use in pregnancy, or they just don’t want to be pregnant because of these risks, rheumatologists need to be certain that women of reproductive age, who don’t want to be pregnant, particularly if they have active disease, are using appropriate birth control,” he adds. “We should avoid the, ‘Oh, I really didn’t want you to get pregnant because I am treating you with this drug or your disease is really active, and, oops, now you are pregnant.’”

Future Implications

More importantly, this study gives rheumatologists a starting point to “look further into the health of babies of RA patients,” according to Dr. Zashin.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:pregnancypreterm birthQuinnResearchRheumatoid arthritisrheumatology

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

    Pregnancy Outcomes in Patients with Psoriatic Arthritis

    March 1, 2022

    In March A&R, Remaeus et al. reported on the results of their study, which evaluated pregnancy outcomes in relation to anti-rheumatic treatment before and during pregnancy, as a proxy of disease severity in pregnant women with psoriatic arthritis (PsA), compared with those without PsA.

    The Chimeric Self

    February 1, 2007

    Michrochimerism research offers insights into several autoimmune conditions

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences